INSULININJECTIONINSULININJECTION Multiple Insulin Injection Therapy.

Slides:



Advertisements
Similar presentations
Insulin Therapy. Insulin Treatment (when?) Any Glucose Level Age Rapid onset Weight loss Tablets fail Pregnancy Illness Ketoacidosis Pancreat-ectomy.
Advertisements

University of Georgia Cooperative Extension. Why Change Eating Habits? To prevent complications of diabetesTo prevent complications of diabetes –by keeping.
Diet Teaching For the Diabetic Patient
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
MEDICAL NUTRITION THERAPY (MNT) Mrs. Sarah Jacob Rtd. Head, Department of Dietetics Christian Medical College Vellore.

Diabetes (abridged!). Who needs screening for DM? Age >45 Obese – BMI >25 1 st degree relative with DM Racial groups: –African American –Hispanic American.
Insulin Diabetes Outreach (June 2011). 2 Insulin Learning outcomes >Understand the difference between insulin therapy in type 1 diabetes as compared to.
Insulin initiation OPTIMISING Glycaemic control and Weight Dr C Rajeswaran Consultant Physician Diabetes & Endocrinology Mid Yorkshire NHS Trust.
Type 2 DM - Case Study Jean Kerver, MS, RD, CDE 2/18/00.
Diabetes. Diabetes Mellitus Disease in which the body doesn’t produce or properly use insulin, leading to hyperglycemia.
The Disease: Type 1 diabetes is an auto-immune condition in which the immune system is activated to destroy the cells in the pancreas which produce insulin.
Coping with Diabetes.
Clinical Protocol Using Insulin Pump Easy Guideline for Initiating Insulin Pumps on Type 2 Diabetes Patients.
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Insulin therapy.
INSULIN THERAPHY Dilum Weliwita B. Sc Nursing ( UK )
DIABETES SELF-MANAGEMENT. Multiple studies have found that DSME is associated with  improved diabetes knowledge,improved self-care behavior  improved.
Nutritional Management of Diabetes at School Betsy Smith, MS, RD Children’s Hospital January 11, 2007.
Hanadi Baeissa Disturbance in Glucose Utilization Diabetes Mellitus- Gestational Diabetes- Impaired Glucose Tolerance- Hypoglycemia.
Insulin therapy Niloufar Ansari, Pharm. D.
CARE OF PATIENTS WITH DIABETES MELLITUS JANNA WICKHAM RN MSN LSSC FALL 2013 Chapter 20.
INSULIN THERAPY IN TYPE 1 DIABETES
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
GDM DIAGNOSIS AND MANAGEMENT
Guidelines for Diabetes Management September 20, 2012 Margaret Pochay RD CDE.
Titrating Insulin to Glycemic Target Judy Bowen, MD CIM Rotation September, 2006.
Basal and Meal Time Insulin Case Study
OnsetPeakDuration Rapid Acting Lispro (Humalog) min3-5 hours Aspart (Novolog)15-30 min1-3 hours3-5 hours Intermediate Acting NPH1-4 hours5-10.
Inpatient Glycemic Management
5/26/2016 8:44 AM Reviewing Carbohydrates. 5/26/2016 8:44 AM Functions of Carbohydrates Why do we need them? Provide Energy Spare Protein Promote Normal.
ANHYDROSIS EXERCISE PREVENTION Helmich, S.P. et al. New England J Medicine 325: , 199 Incidence Rates of type 2 (/ 10,000 man-years.
1. SH.ARBABI, M.D Endocrinology Center 18-OCT-2007.
1 Carb Counting and Insulin Administration Module Georgia Hospital Association Diabetes Special Interest Group.
Diabetes: What’s New? What’s Next? Robert P. Hoffman, M.D. Grand Rounds June 1, 2007.
Diabetes Characterized by an absolute (type 1) or relative (type 2) insulin deficiency that results in hyperglycemia A major health problem and leading.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Dr Stanley Ngare.  Pharmacology of Types of insulin available  Various routes of delivery & factors that affect absorption  Patient and provider barriers.
BY : AQUIL JIM HELEN. What is the diabetes? What is the diabetes? Diabetes is a disease that affects how the body uses glucose (sugar ) that is the body’s.
New Insulin Formulations Guillermo Umpierrez, MD, FACP, FACE Professor of Medicine Emory University School of Medicine Part 1.
Type I Diabetes Mellitus
1 Empowerment Course Presenters: Melba Mensch Course Facilitator Dr Mary Ho CMO and Course Facilitator Dr. Tuan Quach Diabetes Specialist Rosalie Arnold.
Tresiba- insulin degludec
Diabetes ABCs Diabetes Care Centers Henry Ford Health Systems.
18/11/20081 Diabetes mellitus Prepared by Thamer-almangour.
Diabetes Update: Michael Gottschalk, M.D, Ph.D.
Technology to Assist with Diabetes Care February 4, 2011 Margaret Pochay RD CDE.
Diabetes in Pregnancy Diabetes: a leading complication in pregnancy Forms of diabetes include: –Type 1 diabetes—Results from destruction of insulin-producing.
Endocrine System KNH 411. Diabetes Mellitus 7% of population; 1/3 undiagnosed $132 billion in health care Sixth leading cause of death Complications of.
Insulin Pump Therapy Bruce W. Bode, MD and Sandra Weber, MD.
True/False Subtitle. Sports drinks are the best kinds of fluids for athletes?
BND Sport & Exercise Science Sports Nutrition - Diet Plans.
Diabetes Mellitus Part 2 Kathy Martin DNP, RN, CNE.
Special Situations In The Management Of In-Patient Hyperglycemia
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
Insulin Initiation and Titration
Management of DM1 Lec.2 By Dr. Athal Humo
Interventions for Clients with Diabetes Mellitus
Endocrine System KNH 411.
Endocrine System KNH 411.
T1DM: Insulin Initiation
Endocrine System KNH 411.
Diabetes Caused by reduced insulin secretion or resistance to insulin at cell receptor Excess BG and obesity, then insulin resistance, then excess insulin,
Endocrine System KNH 411.
Endocrine System KNH 411.
Endocrine System KNH 411.
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Insulin in Type 2 Diabetes
Hyperglycemic Targets & Hypoglycemia
Presentation transcript:

INSULININJECTIONINSULININJECTION Multiple Insulin Injection Therapy

The presentation Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Introduction: Goals of multiple insulin injection. High light of treatment method. Glycemic control effect. Diet treatment. Type of insulin: Insulin preparation. What to mix and what not to mix. Type of regimen: Western regimen. Our regimen. Future regimen. Important phenomena: Somogyi phenomena. Dawn and predawn phenomena.

Goals Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Clinical Goals: Elimination of ketosis. Elimination of hyperglycemia and it’s symptoms. Prevention of chronic complications. Additional Goals: Maintaining desirable weight. Maintaining normal growth and sexual maturation. Maintaining psychosocial well-being. Achieving normal fertility and pregnancy. Sustaining normal family and sexual life. Control Goals: HbA1c <7%. Pre-meal SMBG mg/dl ( mmol/l). Bed time SMBG mg/dl ( mmol/l). No ketonuria. Mean blood glucose level mg/dl ( mmol/l).

Highlights Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Insulin: Type 1 diabetes is dependent on insulin for survival. Insulin is classified by source or duration of action. Human insulin has less allergy or lipoatrophy. More than one injection is needed and different types. Proper action During honeymoon phase. The commonest side effect is hypoglycemia. Nutrition: Enable near normal blood glucose level. Maintain a reasonable body weight. Protein 10-20%, Fat 15-25%, Carbohydrate 65%. Fibers, vitamins, and minerals. Food exchanges or carbohydrate counting. Total daily calorie intake adjustment. Exercise: Should be integrated. Weight control and improve well being. Pre-exercise medical evaluation. Monitoring: Glucometer use SMBG to monitor blood glucose level. Adjustment of insulin, diet, and exercise. Urine testing for both glucose and ketones. HbA1c the best index for control.

Glycemic control Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Years from randomization Conventional Intensive 6.2% upper limit of normal range HbA 1c (%) UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837–853.

Diet Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Physical activity Body weight 25 years male IBW 60 kgm Carbohydrate (65%)390 Protein (10%) 60 Fat (25%)150 Carbohydrate 100 gm Protein (10%) 15 gm Fat (25%) 17 gm Diet Carbohy. Protein Fat _ Arabian bread 30 gm Cheese 5 gm 10 gm 10 gm Honey 50 gm 2 gm 3 gm Glass of milk 10 gm 5 gm 5 gm_ Total 95 gm 17 gm 18 gm Carbohydrate (65%)520 Protein (10%) 80 Fat (25%)200 Carbohydrate 130 gm Protein (10%) 20 gm Fat (25%) 22 gm Diet Carbohy. Protein Fat _ Rice 80 gm gm chicken 5 gm 15 gm 12 gm Salad 30 gm 4 gm 4 gm Orange 10 gm ___ Total 125 gm 19 gm 22 gm Carbohydrate (65%)260 Protein (10%) 40 Fat (25%)100 Carbohydrate 65 gm Protein (10%) 10 gm Fat (25%) 11 gm Diet Carbohy. Protein Fat _ Tuna sandwich 45 gm 12 gm 10 gm Apple 15 gm Tea _ Total 95 gm 17 gm 18 gm 60 Kg X 30 kcal = 1800 kcal Breakfast 600 kcalLunch 800 kcalDinner 400 kcal The total calories intake depends on patients age and activity but have to related to the desirable body weight. Total daily calories = IBW X Estimated daily energy Total daily calories = IBW X Estimated daily energy Add 300 kcal/day during pregnancy. Add 500 kcal/day during lactation. Fibers, sweeteners, vitamins, and minerals.

Glucose sensor Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION The plan of insulin type and dose will depend on: - The shape of glucose curve. - The diet and exercise.

INSULIN TYPES DURATION OF ACTION Insulin Preparations Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION ActionNameOnsetDuration Very rapidLispro / Novo rapid10-15 min2-3 hrs RapidCrystalline zinc (CZI)30-45 min4-6 hrs IntermediateNeutral Protamine Hagedorn (NPH)1-2 hrs6-12 hrs Lente zinc Long actingUltralente zinc6-8 hrs18 hrs Lantus (glargine)4-8 hrs24 hrs Premixed 80% NPH+20%CZI30-45 min6-12 hrs 70% NPH+30%CZI30-45 min6-12 hrs 50% NPH+50%CZI30-45 min6-12 hrs

Insulin Mixing Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION ActionNameMix (1) Very rapidLispro / Novo rapidYes (2) RapidCrystalline zinc (CZI)Yes (2) IntermediateNeutral ProtamineYes (2) Hagedorn (NPH)Yes (2) Lente zinc Yes (2) Long actingUltralente zincNo Lantus (glargine)No_ Premixed 80% NPH+20%CZINo 70% NPH+30%CZINo 50% NPH+50%CZINo_ (1) Mixing different type of insulin has to be fron the same source (ie same company) (2) Mixing different type of insulin has to be fron the same source (ie same company)

Pre-mixed insulin Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION 10/90 20/80 30/70 40/60 50/50 Post- prandial hyperglycemia Pre-prandial hyperglycemia

Western regimen Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Time of day Insulin (mU/l) Normal free insulin levels (Mean) Simulated s.c. injected soluble human insulin + NPH Adapted from Polonsky et al DinnerNPHBreakfastLunch Simulated s.c. injected insulin aspart + NPH Meal   

Western regimen Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION   Two doses: The usual dosing commonly used. Initial insulin therapy     Four doses: Brittle diabetic patient. Pregnant mothers specially type 1.     Four doses: Brittle diabetic patient. Pregnant mothers specially type 1. Motivated patients.    Three doses: Used for active patients. Patients taking two main meals.

Western regimen Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION   Two doses: The usual dosing commonly used. Initial insulin therapy    Three doses: Used for active patients. Patients taking two main meals.     Four doses: Brittle diabetic patient. Pregnant mothers specially type 1.     Four doses: Brittle diabetic patient. Pregnant mothers specially type 1. Motivated patients.

Blood Glucose Curve Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Glucose variations in our culture:

Insulin Use Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Regular and NPH use twice daily the commonest regimen used. Premixed with different concentration (30/70, 40/60, 50/50). Lunch is the biggest meal usually but no insulin dosing.

Hyper-glycemia window Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Hyperglycemia Window Cause: Lack of insulin Lunch effect afternoon snacks Effect: Pre-meal hyperglycemia  HbA1c by 1.7%

Hyper-glycemia window Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Treat by adding regular dose pre-lunch

Hyper-glycemia window Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Treat by adding regular dose pre-meals and small one before sleep

Hypo-glycemia window Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Hypoglycemia Window Cause: NPH evening dose ? Late sleep Effect: Somogyi effect Week end Problem

Hypo-glycemia window Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Treat by moving am dose late and regular dose pre-supper and NPH at night

Hypo-glycemia window Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Treat by moving am dose late and regular dose pre-supper and another dose pre bed

Somogyi Phenomenon Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Cause: Counter regulatory hormones response to hypoglycemia at med-night. Increase in hepatic glucose production. Insulin resistance because of the Counter regulatory hormones. Treatment: Decrease pre-supper intermediate insulin. Defer the dose to 9 PM. Change or start pre-bed snack.

Dawn Phenomenon Multiple Insulin Injection Therapy INSULININJECTIONINSULININJECTION Cause: Less insulin at bed time. More food at bed time. Not using NPH at night. Treatment: Use enough dose. Reduce bed time snack. Add NPH pre-supper.